Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 9,179,000 | 10,929,000 | 9,353,000 | 12,057,000 | 4,148,000 |
| Cost of Goods | 4,546,000 | 3,013,000 | 2,747,000 | 3,312,000 | 1,573,000 |
| Gross Profit | 4,633,000 | 7,916,000 | 6,606,000 | 8,745,000 | 2,575,000 |
| Operating Expenses | 8,009,000 | 5,409,000 | 4,170,000 | 4,764,000 | 4,129,000 |
| Operating Income | -3,376,000 | 2,507,000 | 2,436,000 | 3,981,000 | -1,554,000 |
| Other Income | -46,000 | 199,000 | 305,000 | -143,000 | 52,000 |
| Pre-tax Income | -3,422,000 | 2,706,000 | 2,741,000 | 3,838,000 | -1,502,000 |
| Income Tax | -55,000 | 380,000 | 396,000 | 619,000 | 305,000 |
| Net Income Continuous | -3,367,000 | 2,326,000 | 2,345,000 | 3,219,000 | -1,807,000 |
| Net Income Discontinuous | 1,270,000 | 617,000 | 661,000 | N/A | N/A |
| Minority Interests | -2,000 | 2,000 | 4,000 | N/A | -11,000 |
| Net Income | $-2,095,000 | $2,941,000 | $3,002,000 | $3,219,000 | $2,357,000 |
| EPS Basic Total Ops | -0.83 | 1.16 | 1.19 | 1.27 | 0.93 |
| EPS Basic Continuous Ops | -1.33 | 0.92 | 0.93 | 1.27 | -0.66 |
| EPS Basic Discontinuous Ops | 0.51 | 0.24 | 0.26 | N/A | N/A |
| EPS Diluted Total Ops | -0.82 | 1.16 | 1.18 | 1.26 | 0.92 |
| EPS Diluted Continuous Ops | -1.32 | 0.92 | 0.92 | 1.26 | -0.65 |
| EPS Diluted Discontinuous Ops | 0.50 | 0.24 | 0.26 | N/A | N/A |
| EBITDA(a) | $-2,493,000 | $3,314,000 | $3,411,000 | $4,802,000 | $-960,000 |